Fi3 FINANCIAL ADVISORS LLC Has $249,000 Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Fi3 FINANCIAL ADVISORS LLC lessened its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 5.5% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 478 shares of the medical equipment provider’s stock after selling 28 shares during the quarter. Fi3 FINANCIAL ADVISORS LLC’s holdings in Intuitive Surgical were worth $249,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently made changes to their positions in ISRG. Atala Financial Inc acquired a new position in Intuitive Surgical during the fourth quarter worth $25,000. Berbice Capital Management LLC acquired a new position in Intuitive Surgical during the fourth quarter worth $26,000. BankPlus Trust Department acquired a new position in Intuitive Surgical during the fourth quarter worth $28,000. Kohmann Bosshard Financial Services LLC acquired a new position in Intuitive Surgical during the fourth quarter worth $31,000. Finally, Decker Retirement Planning Inc. acquired a new position in Intuitive Surgical during the fourth quarter worth $36,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Stock Performance

NASDAQ:ISRG opened at $492.49 on Friday. Intuitive Surgical, Inc. has a 52 week low of $364.17 and a 52 week high of $616.00. The firm has a market cap of $175.41 billion, a price-to-earnings ratio of 76.83, a P/E/G ratio of 5.85 and a beta of 1.43. The firm’s 50-day simple moving average is $562.24 and its 200 day simple moving average is $531.34.

Insider Buying and Selling

In other Intuitive Surgical news, CFO Jamie Samath sold 269 shares of the firm’s stock in a transaction dated Monday, February 10th. The shares were sold at an average price of $590.00, for a total value of $158,710.00. Following the transaction, the chief financial officer now directly owns 3,282 shares of the company’s stock, valued at $1,936,380. This trade represents a 7.58 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Robert Desantis sold 11,545 shares of the firm’s stock in a transaction dated Thursday, March 13th. The shares were sold at an average price of $499.22, for a total transaction of $5,763,494.90. Following the completion of the transaction, the executive vice president now directly owns 5,224 shares in the company, valued at approximately $2,607,925.28. This represents a 68.85 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 33,754 shares of company stock valued at $17,691,621. 0.90% of the stock is owned by company insiders.

Analyst Ratings Changes

Several brokerages recently commented on ISRG. Royal Bank of Canada increased their target price on shares of Intuitive Surgical from $611.00 to $641.00 in a report on Monday, January 27th. Leerink Partners increased their price target on shares of Intuitive Surgical from $490.00 to $548.00 in a research note on Monday, January 27th. Wells Fargo & Company increased their price target on shares of Intuitive Surgical from $630.00 to $687.00 and gave the company an “overweight” rating in a research note on Friday, January 24th. Bernstein Bank increased their price target on shares of Intuitive Surgical from $655.00 to $700.00 and gave the company an “overweight” rating in a research note on Monday, January 27th. Finally, Citigroup increased their price target on shares of Intuitive Surgical from $640.00 to $711.00 and gave the company a “buy” rating in a research note on Friday, January 24th. One analyst has rated the stock with a sell rating, five have assigned a hold rating and fifteen have issued a buy rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $611.86.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.